Previous Article | Next Article 
Journal of Virology, September 2000, p. 8658-8669, Vol. 74, No. 18
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Functional Dissection of the Major Structural Protein of
Bluetongue Virus: Identification of Key Residues within VP7
Essential for Capsid Assembly
Chang-Kwang
Limn,1
Norbert
Staeuber,2,3
Katherine
Monastyrskaya,2,3
Patrice
Gouet,4 and
Polly
Roy1,2,3,*
Department of Medicine, University of Alabama
at Birmingham, Birmingham, Alabama 35294,1 and
NERC Institute of Virology and Environmental Microbiology,
Oxford OX1 3SR,2 and Department of
Biochemistry3 and Laboratory of
Molecular Biophysics,4 University of Oxford,
Oxford OX1 3QU, United Kingdom
Received 28 February 2000/Accepted 8 June 2000
 |
ABSTRACT |
A lattice of VP7 trimers forms the surface of the icosahedral
bluetongue virus (BTV) core. To investigate the role of VP7 oligomerization in core assembly, a series of residues for substitution were predicted based on crystal structures of BTV type 10 VP7 molecule
targeting the monomer-monomer contacts within the trimer. Seven
site-specific substitution mutations of VP7 have been created using
cDNA clones and were employed to produce seven recombinant baculoviruses. The effects of these mutations on VP7 solubility, ability to trimerize and formation of core-like particles (CLPs) in the
presence of the scaffolding VP3 protein, were investigated. Of the
seven VP7 mutants examined, three severely affected the stability of
CLP, while two other mutants had lesser effect on CLP stability. Only
one mutant had no apparent effect on the formation of the stable
capsid. One mutant in which the conserved tyrosine at residue 271 (lower domain helix 6) was replaced by arginine formed insoluble
aggregates, implying an effect in the folding of the molecule despite
the prediction that such a change would be accommodated. All six
soluble VP7 mutants were purified, and their ability to trimerize was
examined. All mutants, including those that did not form stable CLPs,
assembled into stable trimers, implying that single substitution may
not be sufficient to perturb the complex monomer-monomer contacts,
although subtle changes within the VP7 trimer could destabilize the
core. The study highlights some of the key residues that are crucial
for BTV core assembly and illustrates how the structure of VP7 in
isolation underrepresents the dynamic nature of the assembly process at
the biological level.
 |
INTRODUCTION |
Orbiviruses, members of the
Reoviridae family, possess a large (86 nm in diameter)
nonenveloped virus particle, encapsidating 10 segments of
double-stranded RNA genome (31, 32, 35). Orbivirus virions
are composed of a number of discrete proteins arranged in a specific
but nonequimolar ratio. Overall, these viruses are icosahedral, with
two protein layers that have radically different geometries, and
provide a complex subject to study, both in terms of protein-protein
interactions, and protein-RNA interactions. Bluetongue virus (BTV), the
prototype orbivirus, consists of seven structural proteins (VP1 to
VP7), four of which are major (VP2, VP3, VP5, and VP7) and include
proteins that interact with cellular receptors and others that form the
underlying framework of the virion (30, 31, 32). The three
minor proteins (VP1, VP4, and VP6), which are present in low molar
ratios within the virion, have RNA transcriptase- and RNA-modifying
properties (33). In its mature form the virus exhibits no
transcriptase activity until it is activated upon infection with the
modification of the outer capsid to create channels in the core
architecture that allow metabolites to enter the capsid and the viral
mRNA species to be formed and extruded (10, 12, 13, 29).
A considerable amount of data has recently been accumulated on the
transcriptionally active BTV core architecture. A combination of
three-dimensional cryo-electron microscopic analysis of the BTV core at
a 25-Å resolution and X-ray crystallographic structure of the BTV core
at a 3.5-Å resolution has revealed the complexity in the arrangements
of the core protein, in particular, how the two major core proteins,
VP7 (Mr 38,000) and VP3
(Mr, 103,000) are organized within the core
(12, 13). The bristly surface of the 70-nm icosahedral core
is made up of 13 icosahedrally independent copies of the VP7 molecule
in the form of four trimers (P, Q, R, and S) in general positions and
one (T) located with its threefold axis aligned with the icosahedral
threefold axis (12, 13, 29). A total of 780 VP7 molecules
form the entire core surface. The local threefold axes of these 260 trimers (85 Å long) are perpendicular to the core surface, and the
broad, flat base of each of the trimers (65 Å) contacts the inner
subcore (11-13). The underlying scaffold is a thin shell,
made up of 120 copies of VP3 molecule that are arranged at T=2
icosahedral symmetry within the subcore layer. The VP7 and VP3 layers
interact through flat, predominantly hydrophobic surfaces. There are 13 different sites of contact for the VP7 subunit on the VP3 subcore.
Since VP7 forms trimers in solution (4), it is likely that
trimers are the driving force for VP7 and VP3 interactions during core assembly. However, as yet there have been no studies delineating trimer
formation from core assembly.
The crystal structure of VP7 at a 2.6-Å resolution has revealed that
three molecules interact extensively to form VP7 trimers (13). Each VP7 subunit or monomer consists of two distinct
domains, the upper and lower, and are twisted such that the top domain of one monomer rests on the lower domain of a threefold related subunit. The interactions between monomers involve both domains and are
extensive. However, there are significant cavities at the center of the
trimer (along the threefold axis) surrounded by predominantly uncharged
residues (11, 13).
To develop an understanding of the assembly process of BTV particles
and the role played by VP7 in capsid assembly, we have focused on the
lower domain of the VP7 molecule, as not only are the lower domains
directly in contact with VP3 layer, but also interactions between the
lower domains within the trimers are intensive (11, 13). A
series of substitutions of amino acid residues have been designed
which, based on the X-ray structure, appeared to be involved in
intramolecular (within the VP7 subunit) and intermolecular (between the
VP7 subunits) interactions within the molecule. Their role in
trimer-trimer interaction was, however, unclear. Each mutant VP7
molecule was expressed in insect cells infected with recombinant
baculoviruses, and the effects of these mutations on the overall VP7
structure (i.e., correct folding) and on core assembly were analyzed
using previously established biological assay systems (9,
25). The formation of the lattice of VP7 trimers on the VP3 layer
was examined by an in vivo expression system in which BTV core-like
particles (CLPs) are assembled upon coexpression of VP7 and VP3 in
insect cells (9). The interaction of VP7 with VP3 within the
CLP was also determined by electron microscopy (EM). Trimerization of
VP7 was assessed by two different experimental approaches using
purified VP7 mutants. It was clear that a single substitution at a key
position could destabilize BTV core assembly without drastically
disrupting the trimer formation. From these analyses, key residues
within the lower domain of VP7 that are essential for core formation
were identified.
 |
MATERIALS AND METHODS |
Viruses and cells.
Spodoptera frugiperda
(Sf) cells were grown in suspension or monolayer cultures at
28°C in TC100 medium supplemented with 10% fetal calf serum.
Derivatives of Autographa californica nuclear polyhedrosis
virus (AcNPV) containing the wild-type BTV type 10 (BTV-10) VP7 gene
(Ac10BTV7) and the VP7 mutants were plaque purified and propagated as
described elsewhere (6).
Site-directed mutagenesis, construction of recombinant transfer
vectors, and isolation of recombinant baculoviruses expressing mutant
VP7 proteins.
Using the single-strand capacity of the baculovirus
transfer vector pAcCL29 (24), synthetic oligonucleotides
were employed to prepare VP7 mutants by the method described by Kunkel
and associates (22). Wild-type BTV-10 VP7 DNA was recovered
from the transfer vector pAcYM1.10BTV7 (27) by excision with
BamHI and subcloned into the BamHI site of
pAcCL29. The oligonucleotides used for mutagenesis and the resulting
amino acid changes are shown in Table 1.
All the oligonucleotides represent the complement of the coding strand
of the BTV-10 gene. The mutated sequences in the recombinant plasmids
were identified by sequence analyses (36).
The lipofection technique (
8) was used to cotransfect
monolayers of
Sf cells with recombinant transfer vectors and
Bsu36I
triple-cut AcNPV DNA (
17). Recombinant
baculoviruses were selected
on the basis of their LacZ-negative
phenotypes, plaque purified,
and propagated as described elsewhere
(
16).
Purification of CLPs.
Baculovirus-expressed CLPs were
purified as described previously (9). In brief,
Sf cells were coinfected in suspension culture with
recombinant baculovirus, Ac17BTV3 expressing VP3 together with the
various mutant VP7 baculoviruses or recombinant baculovirus Ac10BTVP7
expressing wild-type VP7, using a multiplicity of infection of 5 to 10 PFU per cell. After incubation at 28°C for 48 h, cells were
harvested, washed with phosphate-buffered saline (PBS), resuspended in
TNN buffer (200 mM Tris-HCl [pH 8.0], 150 mM NaCl, 0.5% [vol/vol]
Nonidet P-40) and lysed by Dounce homogenization. The lysate was
clarified by centrifugation (10 min at 10,000 rpm using a JA-12 rotor)
and the CLPs were purified from the supernatant by centrifugation on a
(35%) CsCl gradient for 18 h at 35,000 rpm (Beckman SW41 rotor).
Alternatively, CLPs were concentrated by a discontinuous sucrose step
gradient (66% [wt/wt] and 40% [wt/vol] sucrose in 200 mM Tris-HCl
[pH 8.0], 150 mM NaCl) and centrifuged for 3 h at 26,000 rpm
using an SW28 rotor. CLPs were collected from the interface as
described previously (9). The presence of VP3 and VP7
proteins was analyzed by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE), Western blotting using anti-BTV-10
polyclonal antibodies, and by EM.
SDS-PAGE and Western blot analyses.
Sf cell monolayers
were infected with each recombinant baculovirus using a multiplicity of
infection of 10 (9). Cells were harvested at 48 h
postinfection, washed with PBS and lysed at 4°C in TNN buffer.
Samples were then boiled in protein dissociation buffer (10%
[vol/vol]
-mercaptoethanol, 10% [wt/vol] SDS, 25% [vol/vol]
glycerol, 10 mM Tris-HCl [pH 6.8], and 0.02% [wt/vol] bromophenol
blue) at 100°C or at room temperature (for identification of VP7
trimers) for 10 min and resolved by SDS-10% PAGE followed by staining
with Coomassie brilliant blue.
For Western blot analyses proteins were transferred from gels onto a
polyvinylidene difluoride membrane by standard blotting
procedures.
Membranes were incubated with the anti BTV-10 antiserum
diluted 1:1,000
in blocking buffer (containing 5% [wt/vol] skim
milk and 0.05%
[vol/vol] Tween 20 in PBS), followed by incubation
with the secondary
antibody conjugated with alkaline phosphatase,
and developed with the
alkaline phosphatase substrate (NBT-BCIP
[GIBCO-BRL] in 0.1 M
Tris-HCl [pH 8.5], 0.1 M NaCl, 0.05 M MgCl
2).
Purification of recombinant VP7 protein by ammonium sulfate
precipitation.
The wild-type and mutant BTV-10 VP7 proteins were
purified as described previously (4). The infected
Sf cells were harvested 48 h postinfection, washed in
PBS, resuspended in cold TNN buffer, and homogenized at 4°C as
described above. Cell debris and nuclei were pelleted by centrifugation
(10 min at 16,000 × g). Ice-cold saturated ammonium
sulfate in 100 mM Tris-HCl, pH 7.5 was added to the cytoplasmic cell
extracts to a final concentration of 20%. The precipitated protein was
pelleted by centrifugation and resuspended in 10 mM Tris-HCl, pH 8.5. The insoluble material was removed by pelleting at 9,000 × g for 10 min and then dialyzed against the same buffer at 4°C
overnight. The extract of VP7 was stored at
20°C prior to analysis.
Velocity sedimentation analysis.
Purified VP7 protein was
applied onto 15 to 30% (vol/vol) glycerol gradients made in 20 mM Tris
(pH 8.0)-100 mM NaCl-1 mM dithiothreitol-0.5 mM EDTA and sedimented
at 60,000 rpm in a Beckman VTi 65 rotor at 4°C for 90 min. Molecular
mass markers in the gradients were provided by high-molecular-mass
calibration kits (Pharmacia). The molecular mass standard consisted of
the following proteins: catalase, 4 × 58 kDa = 232 kDa;
lactate dehydrogenase, 4 × 36 kDa = 140 kDa; and serum
albumin, 67 kDa. Gradients were fractionated from the bottom, and VP7
molecules were detected by SDS-PAGE and Western blotting.
EM.
Purified wild-type and mutant CLPs were resuspended in
water, and 10 µl of CLPs were absorbed onto carbon-coated copper
400-mesh EM grids for 15 min, washed with water, and negatively stained with 1% (wt/vol) uranyl acetate. Grids were examined in a Hitachi H-7000 electron microscope at 75 kV.
 |
RESULTS |
Rationale for selection of residues within VP7 for site-specific
mutagenesis.
The amino acid sequence of VP7 protein is highly
conserved among BTV serotypes (up to 99% identity) and other closely
related orbiviruses, such as epizootic hemorrhagic disease virus (EHDV) (64% identity) and African horse sickness virus (AHSV) (45% identity) (7, 10, 18, 20, 30-35, 37). Several amino acid residues were selected for mutagenesis studies on the basis of their positions in the X-ray structure of the BTV VP7 molecule as well as their conservation between BTV, EHDV, and AHSV (Fig.
1). The lower domain of VP7, which
contains both the N terminus (amino acids 1 to 120) and the C terminus
(aa 250 to 349) of the molecule, is composed entirely of
-helices
(nine in total) and long extended loops (11). The N-terminal
portion provides five of these helices, with the remaining four helices
formed by the C-terminal region (Fig. 1 and
2). The helices of the lower domain are
packed tightly together (Fig. 2). The interactions between the three
VP7 lower domains in the trimer are complex and mostly involve helices
5 and 6 and associated loops (11). Helix 5 is located inside
the trimer, interacting with helices 1, 2, 6, and 8. Helix 6 runs across the top of the lower domain, interacting with both the clockwise
and anticlockwise related subunits. Our aims were to substitute key
residues in these helices and loops with alternative residues and to
assess their effect in VP7 trimer formation and core assembly. These
mutants would allow us to assess to what extent these specific contact
points could be varied. Some of these residues were selected since they
are highly conserved among VP7 molecules of three related orbiviruses
and to replace these with residues that should be accommodated within
the molecule without too drastic effect. Based on the structural
analysis, we selected two residues of helix 5 (E104 and R111), one
residue of a loop at the end of helix 5 (W119), two residues of helix 6 (F268 and Y271), and two residues of helix 8 (D318 and T321), respectively, for mutational studies (Table
2).

View larger version (85K):
[in this window]
[in a new window]
|
FIG. 1.
Important features relative to VP7 BTV-10 sequence.
Residues conserved (1) in VP7 of BTV-10, AHSV type 4 (AHSV-4), and EHDV type 1 (EHDV-1) the three gnat-transmitted
orbiviruses (1, 15, 26, 34), are shown in black squares. The
seven mutated residues are indicated by stars on the bottom line;
vertical arrows show the beginning and the end of the top domain.
Secondary elements of VP7 BTV-10 (2, 13) are shown on the
top line. - and 310-helices are indicated by spirals;
-strands are indicated by horizontal arrows.
|
|

View larger version (58K):
[in this window]
[in a new window]
|
FIG. 2.
Ribbon diagram of BTV-10 VP7 trimer. Sites of mutation
are indicated with the three subunits, a, b, and c, which are related
by a threefold molecular axis. Subunit a (cyan), contains helices 5, 6, and 8, in which mutations have been introduced. The b and c subunits
are colored yellow and grey, respectively. Details of the mutation are
highlighted by ball-and-stick representation. Oxygen is shown in red
and nitrogen is shown in blue. Hydrogen bonds on side chains are shown
by a dashed line. The Figure was drawn with MOLSCRIPT (21)
as modified by R. Esnouf.
|
|
Residues on helix 5.
Helix 5 of the lower domain consists of
15 residues, amino acids 103 to 118, (TEAANEIARVTGETS). The first
glutamate at position 104 (E104) of helix 5 is located at an
interesting site in the molecule as shown in Fig. 2 (also see Fig. 9).
It is located at the bottom of a small cavity in the middle of the VP7
trimer; it does not make close contact with any other residue within
the subunit. However, it has weak interactions (3.9-Å gap), with the residues of the threefold related subunits close to the molecular threefold axis (Fig. 2). Therefore, we predicted that substitution of
this residue with a bulky residue such as W, or F, or Y can be
accommodated without perturbing the protein folding, although it may
affect the shape of the trimer. We chose to replace E104 with
tryptophan (W). The arginine at position 111 (R111) is conserved among
BTV serotypes and in AHSV and EHDV (Fig. 1). The R111 is surface
accessible and surrounds the small cavity (Fig. 2). Therefore, its
substitution by a bulky hydrophobic residue, such as phenylalanine (F),
should not interfere in trimerization. However, unlike E104, it is in
contact with E266 (see Fig. 9) of the neighboring subunit via a side
chain hydrogen bond (11). Therefore, there is a possibility that this substitution may affect the stable monomer-monomer contacts.
The tryptophan at 119 (W119) is part of the loop at the end of helix 5, is located on the surface of the molecule, weakly
interacting with R341
of the partner subunit, and is far away
from the VP7-VP3 interface.
From the atomic structure and our
previous deletion mutation studies,
it appears that the residues
334 to 349 at the carboxy terminus of VP7
are essential for trimer-trimer
interactions in the core (
13,
23). W119 is also near K255,
which is critical for the correct
folding of the VP7 molecule.
It was, therefore, of interest to
determine whether replacement
of W119 by a charged residue, such as
an aspartate, would affect
the trimerization of
VP7.
Residues on helix 6.
Helix 6 is the major element that lines
up with the internal cavity. Most residues appear not to be involved in
close interactions with the partner subunits. For example, as shown in
Fig. 2, none of the residues appear to be near the side chain of
phenylalanine at position 268 (F268) of helix 6. However, it packs
against a lysine residue at residue 255, which is located in the hinge
region between the bottom domain and the top domain. Replacement of
F268 by a large charged side chain, such as arginine, should bring residue 268 close to a residue in the vicinity (such as the proline at
121 [P121]), since arginine is longer (by at least ~20 Å) than phenyalanine. This substitution may or may not influence the
trimerization. F268 was therefore replaced with arginine. A neighboring
tyrosine at position 271 (Y271) of the helix 6 is highly conserved
among other orbiviruses. There are strong nonpolar interactions
between Y271 and P292 (see Fig. 9). Therefore, Y271 was also selected for replacement by an arginine (Y271R), which may interfere with the
trimer formation due to incorporation of charged residues in the
nonpolar pocket.
Residues on helix 8.
Helix 8 is directly in contact with helix
5, packing closely against it. The two residues that were selected for
mutagenesis are involved in contacts between the two helices. The
aspartic acid at position 318 (D318) was replaced by asparagine (D318N) (Table 2), which is an isosteric mutation, in which the size of the
side chain remains unchanged. However, the loss of charge on the side
chain would only weaken the strong hydrogen bond (or the salt link)
between the Asp and Arg residues, since this residue is in contact with
R111 in the partner subunit and thus might affect VP7 trimer formation
due to repulsion force and, consequently, CLP assembly. T321 was
selected for replacement by arginine (T321R) (Table 2) as it is at the
end of helix 8 and close to the surface of the trimer (Fig. 2). The
latter should not affect the trimer formation.
Synthesis of recombinant VP7 mutants and influence of substitution
on VP7 solubility.
We prepared the seven mutations on VP7
DNA as described in Materials and Methods, each having a
single substitution (e.g., E104W, R111F, W119D, F268R, Y271R,
D318N, and T321R) in the lower domain of the molecule. Each VP7
derivative DNA was then cloned into the baculovirus single-stranded
transfer vector, pAcCL29, as described in Materials and Methods. Seven
recombinant baculoviruses were isolated, each expressing a single
mutant VP7 molecule. The supernatants recovered from the recombinant
virus-infected insect cell lysates were examined for the presence of
VP7 mutants. Except one, Y271R, synthesis of VP7 protein was present in
all six mutants, when analyzed by SDS-PAGE and Western analysis,
indicating that the expressed products were in soluble form. Therefore,
none of the six remaining mutations had any apparent drastic effects on VP7 solubility. As expected, when compared with the native VP7 protein,
both the levels of expression and sizes of the mutant proteins in
SDS-PAGE were similar to those of the wild-type VP7, as shown in Fig.
3 (27). It was therefore
considered that each of the six mutants probably had characteristics
that were overall similar to those of the wild-type VP7.

View larger version (108K):
[in this window]
[in a new window]
|
FIG. 3.
Expression of recombinant VP7 mutants. Sf
cells were infected with each recombinant virus, and the infected-cell
lysates were analyzed by SDS-10% PAGE and stained with Coomassie
brilliant blue. Each mutant protein is indicated. The sizes of the
expressed proteins are compared with the purified wild-type VP7 protein
as indicated (WT). The position of VP7 is shown by an arrow.
|
|
Since the recombinant Y271R mutant protein was not detectable from the
solubilized supernatant fraction of the infected-cell
lysate, it was
assumed that Y271R protein was precipitated with
the cell debris upon
low-speed centrifugation. Indeed, high-level
expression of mutant Y271R
protein could be detected in the cell
pellet when analyzed by SDS-PAGE
(Fig.
4, lane 3). The expressed
protein
was clearly insoluble and formed aggregated inclusion
bodies in
infected cells. Due to this it was impossible to recover
it in a native
soluble form. It was therefore concluded that the
arginine for
phenylalanine substitution disrupted the packing
of the N- and
C-terminal helical domains within the VP7 subunit.
No further
characterization was performed with this mutant.

View larger version (78K):
[in this window]
[in a new window]
|
FIG. 4.
Solubility assay of the 10BTV7-Y271R mutant. Following
lysis with nonionic detergent, extracts of the baculovirus-infected
Sf cells were separated by low-speed centrifugation. The
supernatant and the pellet were resolved by SDS-10% PAGE and
Coomassie brilliant blue staining. The lanes shown contain purified
wild-type VP7 protein (WT), supernatant after a low-speed
centrifugation (Sup.), and the pellet after low-speed centrifugation.
|
|
VP7-VP7 interaction at certain specific contact points dictates the
assembly of stable capsid.
The X-ray structure of the BTV core
revealed that although various VP7 trimers interact with VP3 layers
differently, the VP7-VP7 interaction is relatively well fitting and the
various VP7 trimers remain virtually uniform in the complex core
structure (13). Of the five different trimers, the T trimers
seem to be the most tightly attached and are probably the first set of
trimers that attach to the VP3 layer, and the P trimer is the most
loosely attached and probably the last to assemble (12, 13).
Although the substitution mutations were designed to influence the
oligomerization of VP7, they may also be able to influence the
stability of the VP7-VP3 interaction. An attempt was, therefore, made
to investigate whether mutant derivatives of the VP7 molecule could
indeed assemble into the BTV capsid. This was performed by employing a
biological assembly assay that we had developed previously
(9). Each recombinant virus (but not Y271R) was coexpressed
together with VP3 protein in insect cells as described in Materials and
Methods. Two days postinfection, cells were lysed with nonionic
detergent, and the assembled CLPs in the soluble supernatant fraction
were purified through a cesium chloride gradient. Only three mutants
(E104W, D318N, and F268R) of the six recombinant proteins were able to form the particulate structures that could easily be visualized as
bands on the CsCl gradients upon centrifugation and at the same
position as the native CLPs. Evidently, either the other three
mutants, R111F, W119D, and T32R, did not assemble at all, or the
assembled particles were too weak to tolerate the cesium chloride
gradient purification (Table 3).
The morphology for purified CLPs formed by E104W, D318N, and F265R VP7
were characterized by EM. The arrangement of the VP7
capsomers on the
outer layers of these purified particles appeared
more or less dense
and regular, similar to the wild-type CLPs.
In all three cases, the VP3
inner layer of the CLPs was conserved,
exhibiting a thin layer of
an icosahedral configuration. However,
while in the case of E104W
the EM revealed empty CLPs (Fig.
5B)
similar in size and appearance to
wild-type CLPs (Fig.
5A), the
CLPs formed
by mutants D318N and F268R were more heterogeneous.
Many
particles with only VP3 subcore could be seen in the case
of
mutant F268R (Fig.
5D), and a few were seen with D318N (Fig.
5C). This
is probably due to loss of VP7 trimers from these particles
during purification and the fixation treatments required for EM.


View larger version (222K):
[in this window]
[in a new window]
|
FIG. 5.
CLP formation by BTV-17 VP3 and mutated VP7 proteins.
Sf cells were coinfected with Ac17BTV3 and either Ac10BTV7,
expressing the wild-type VP7, or recombinant baculoviruses expressing
various VP7 mutants. The CLPs were purified on CsCl gradients as
described in Materials and Methods. Shown are the results of EM of CLPs
formed by native VP3 protein and native VP7 (A) or different mutant VP7
E104W (B), D318N (C), and F268F (D) proteins. (E) CLPs were analyzed by
SDS-PAGE (each CLP indicated at the top). The positions of VP3 and VP7
are indicated.
|
|
The efficiency of these VP7 mutants to assemble with the VP3
subcore and form CLPs was further assessed by biochemical analysis.
When analyzed by SDS-PAGE (Fig.
5E), it was obvious that E104W
formed
CLPs in the presence of VP3 that were indistinguishable
from the
wild-type CLPs. CLPs formed by the other two mutants,
D318R and F268R,
had fewer VP7 proteins than did native CLPs and
the
difference could easily be visualized upon SDS-PAGE. In particular,
CLPs formed with mutant F268R VP7 had very few VP7 molecules,
indicating that most VP7 molecules were lost during
purification.
The numbers of VP7 molecules present in each type of CLPs were
subsequently estimated. The Coomassie-stained protein bands
of each
preparation were scanned, and the molar ratio of VP3 to
VP7 in each CLP
preparation was estimated. Since purified wild-type
CLPs usually lack
the P trimers (i.e., only 200 trimers/CLP are
generally present), 600 VP7 molecules per 120 molecules of VP3
in each CLP were considered the
full complement (
14; B. V. V.
Prasad,
personal communication). As shown in Fig.
6, while all
of the VP7 trimers were
accounted for in CLPs formed by E104W,
only approximately one-third of
VP7 molecules were present in
CLPs formed by D318N and only a very few
VP7 trimers (<20) remained
attached to the VP3 layer.

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 6.
Number of VP7 molecules per CLP. CsCl gradient-purified
CLPs were resolved by SDS-PAGE, and the image of the gel was captured
and analyzed by AlphaImager 2000 v.3.2 software (Alpha Innotech
Co.). The number of VP7 molecules per CLP was calculated by the ratio
of the density of VP7 to VP3, with VP3 as the denominator. From left to
right, the bars represent wild-type VP7, VP7-E104W, VP7-D318N, and
VP7-F268R, respectively.
|
|
It is possible that the remaining three VP7 mutants, R111F, W119D, and
T321R, were able to assemble into CLPs but were too
fragile to tolerate
the purification by the CsCl gradient centrifugation.
In order to
verify this, an alternative method of CLP isolation
was used. CLPs were
concentrated from the infected cell's supernatants
on a discontinuous
step gradient of sucrose instead of CsCl gradient.
The material after
centrifugation was recovered from the interface
at the top of the 66%
sucrose cushion and examined by EM. As shown
in Fig.
7, a few particles were clearly visible
in each case,
indicating that all three mutants interacted with VP3 and
assembled
as CLPs, albeit the assembled particles appeared to be much
less
abundant than native capsomers. Therefore, it was concluded that
these mutants have the ability to assemble, although the
assembled
particles were highly unstable. It is noteworthy that
in similar
analyses with the CLPs formed by the other three mutants
(E104W,
D318N, and F268R), the CLPs appeared to have much more VP7
trimer
on the surface (data not shown).

View larger version (85K):
[in this window]
[in a new window]
|
FIG. 7.
EM of unpurified CLPs formed by VP7 mutants.
Sf cells were coinfected with Ac17BTV-3 and one of the
mutant viruses expressing either R111F, T321R, or W1119D. The
infected-cell lysates were loaded onto a discontinuous sucrose step
gradient (66% [wt/wt]) and 40% [wt/vol]) in 200 mM Tris-HCl (pH
8.0)-150 mM NaCl and centrifuged for 3 h on an SW28 rotor at
26,000 rpm. The interface above the 66% sucrose was collected and
visualized by EM as described in Materials and Methods.
|
|
Substitution mutations at key residues in VP7 do not perturb
trimerization.
Of the six soluble VP7 proteins, most were able to
assemble in vivo with the VP3 subcore layer, albeit at various degrees of stability. These variations were likely due to different extents of
intermolecular contact within the VP7 trimers. Weakening of these
contacts would lead to the formation of unstable oligomers. Therefore,
the effects of substitution mutations on VP7 trimer formation were
analyzed on each of these recombinant proteins. Since it is not
possible to investigate the oligomerization of the expressed proteins
in crude extracts, each expressed protein was therefore partially
purified from soluble supernatant fractions. Purification of each VP7
mutant was successfully achieved using the same purification regimen
previously established for wild-type recombinant VP7 (4). It
was assumed, therefore, that the overall biochemical features of each
mutant protein were similar to that of the wild-type VP7. Each purified
preparation was used for trimerization assay using two different
methods, first, SDS-PAGE analysis of unboiled samples that have
previously been established to detect VP7 oligomers (25),
and second, glycerol gradient sedimentation of the oligomers. Much to
our surprise, all VP7 mutants were able to form trimers that
could easily be detected by SDS-PAGE, similar to those of
wild-type recombinant protein (Table 3). As shown in Fig.
8, not only did E104W,
D318N, and F268R form trimers (Fig. 8A) as expected, but also the other
three VP7 mutants, R111F, W119D, and T321R, showed dimeric and trimeric
bands and at an easily detectable level. However, dimers were not
detectable for the first three mutants, indicating that the stable
trimers were formed easily. The ability of these mutant VP7 proteins to
form oligomers was also confirmed by an alternative glycerol gradient sedimentation. As expected, when analyzed by the gradient fractions and
SDS-PAGE, the trimers were detected in each mutant sample, including
R111F, W119D, and T321R (Fig. 8B and C). However, dimers and trimers
were not segregated on the gradient used. It was therefore assumed that
even though the assembled particles formed by these mutants were not
stable, these mutants could still form oligomers that were reasonably
stable. The data clearly indicate that these substitution mutants were
able to form the trimers in solution.

View larger version (81K):
[in this window]
[in a new window]
|
FIG. 8.
Trimerization assay of the wild-type and mutated BTV-10
VP7. Recombinant wild-type BTV-10 VP7 and VP7 mutants were purified and
assayed for trimer formation as described in Materials and Methods. (A
and B) Coomassie blue-stained SDS-PAGE profiles of boiled and unboiled
(RT) VP7 samples. The mutants and wild type (WT) are indicated. The
positions of VP7 monomer, dimer, and trimer are indicated. (C)
Sedimentation profiles of soluble VP7 protein on glycerol gradients.
Following purification, soluble VP7 mutants were subjected to velocity
sedimentation analysis on 15-to-30% glycerol gradients to separate VP7
trimers. Fractions from the bottom to the top (left to right) were
subjected to SDS-PAGE. An arrow marks the sedimented position of VP7.
(a) High-molecular-weight calibration markers (in thousands [K])
consisting of catalase (4 × 58 K = 232 K), lactate
dehydrogenase (4 × 36 K = 140 K), and serum albumin (67 K);
(b) wild-type VP7; (c) W119D, stained with Coomassie brilliant blue.
Lane M shows molecular weight markers (Bio-Rad) for SDS-PAGE. (D)
Western analysis of SDS-PAGE of wild-type VP7 and three VP7 mutants as
indicated.
|
|
The stability of each mutant in comparison to the wild-type VP7 was
further assessed by Western blot analysis. By such analysis,
it was
possible to visualize differences in relative amounts of
VP7 oligomers
(Fig.
8D). Clearly each of the three mutant proteins
exhibited fewer
trimeric forms than monomeric and dimeric forms.
In contrast, the
native VP7 shows much higher amount of trimers.
This is probably due to
the fact that these mutant VP7 trimers
are not as stable as the trimers
formed by the wild-type VP7 and
that the mutant oligomers disassemble
easily.
Data obtained from trimerization studies together with the data
obtained from CLP assembly indicate that the formation of
trimers by
these VP7 derivatives is not sufficient to generate
stable VP3-VP7
interaction, probably due to unstable trimer-trimer
interaction and CLP
assembly. It is therefore likely that the
nature (e.g., shape) of VP7
trimers may also play a crucial role
in core
assembly.
 |
DISCUSSION |
The self-assembly of the BTV VP3 and VP7 proteins into
empty CLPs, observed after coexpression of their respective genes in insect cells using recombinant baculoviruses (9), provides a
useful model for studying some of the BTV protein-protein interactions that may occur during virus assembly. Before the structure of VP7 was
determined, a number of regions essential for the interaction of VP7
and VP3 in CLP formation were mapped by site-directed and deletion-insertion mutagenesis (5, 23). It was demonstrated that replacement of the conserved K255 by L or removal of 14 amino acids from the carboxy terminus of BTV-10 VP7 abrogated CLP formation, possibly by interfering with protein folding and/or trimerization.
The crystal structure of VP7 has revealed a highly unusual
molecular organization (11). The
-sandwich
structure of the top domain of VP7 resembles a jellyroll, similar to
that of majority of other viral capsid proteins (11). In
contrast, the
-helical bottom domain is not commonly observed in
viral capsid proteins. The crystallographic data suggested that the
lower domain of VP7 is responsible for interactions with the VP3 layer
in the core via the flat hydrophobic area at the base of the VP7
trimers (11). This has recently been confirmed by the X-ray
structure of the BTV core, which also revealed how the VP7 layer in the
core avoids the need for different protein conformations for
trimer-trimer interaction by creating a thin band around the
-helical bottom domain (13).
Site-directed mutagenesis was used to investigate the role of the VP7
lower domain, specifically, helices 5, 6, and 8 and associated loops in
CLP assembly. Several amino acid residues in these helices were
selected on the basis of their position and conserved nature among the
three orbivirus VP7 proteins. Four residues (E104, R111, Y271, and
D318), two from helix 5 and one each from helix 6 and 8, respectively,
that are conserved among the related orbiviruses were chosen and
exchanged for either more bulky residues (E104W or R111F) or uncharged
to charged hydrophilic residues (Y271R) or vice versa (D318N). While it
was predicted that a mutation at E104 would not affect either the
oligomerization or CLP formation due to its position in the molecule,
the other three substitution mutations were likely to have some affect
on CLP assembly, as these substitutions should weaken the contacts between the helices. Indeed replacing E104 with tryptophan did not
affect the formation of VP7 trimers and their interaction with VP3. In
the atomic structure (Fig. 9) there are
not many close interactions between E104 and the neighboring arginine
residues and there was a lot of space to fit the bulky W residue;
hence, there was no apparent effect on CLP assembly. On the other hand, loss of a charge at residue 318, i.e., replacement of aspartate by
asparagine, had a greater effect on CLP assembly, yielding only CLPs
with one-third of the trimer intact. Mutation at R111 had more severe
effect on capsid assembly. It is likely that changing the arginine to
phenyalanine (Fig. 9) led to loss of two salt links between the
subunits and thus resulted in weaker contacts within the trimer. It
might have affected the overall nature (e.g., shape) of the trimer,
which would have had an indirect effect on the assembly of the VP7
trimers on the VP3 subcore. VP3 subcores are highly unstable when
assembled in the absence of VP7 molecules. Therefore, it is not
surprising that no band could be visualized on CsCl gradient
centrifugation for R111F CLPs. Nevertheless, when the crude soluble
products were concentrated on a sucrose cushion, a few assembled CLPs
could still be detected by EM, implying that the contact between VP3
and VP7 did occur, although it appeared to be extremely unstable. These
three mutant VP7 proteins were all highly soluble and could trimerize
in solution. In contrast, the replacement of the conserved tyrosine at
residue 271 (helix 6) by arginine resulted in aggregation of the
mutated protein. Tyrosine 271, as a part of a hydrophobic cluster (Fig.
9), contacts the neighboring proline (aa 292). The replacement by
arginine might have disturbed this hydrophobic region and interfered
with the proper folding of VP7 and its interaction with proline (aa 292), a residue that is known to be crucial for folding and stability (28).

View larger version (91K):
[in this window]
[in a new window]
|
FIG. 9.
Position of each residue mutated and the
surrounding environment within a trimer. The amino acids charged are
highlighted as ball-and-stick models on a wire frame background.
Hydrogen bonding between residues is indicated by dashed lines, and the
relevant spacing is shown in angstroms. The environment of each
mutation is shown for one monomer-monomer interface only, with the
residues derived from each monomer designated by a, b, or c. The
residues mutated are E104 (A), R111 (B), W119 (C), F268 (D), Y271 (E),
and T321 (F).
|
|
Of the second set of mutants, the residue F268 located on helix 6 maintains a close contact with neighboring residues. The residue F268
also rests against a lysine residue at 255 of the hinge region. Similar
structural features are associated with residue W119, which is located
just beyond helix 5 and in contact with helix 9, although, while both
F268R and W119D could still form stable trimers and could be detected
by SDS-PAGE, only F268R assembled with VP3 subcore and could be
isolated in purified forms. However, the W119D failed to attach
strongly onto VP3 subcore, and consequently resultant CLPs could not
tolerate the CsCl gradient purification. The long side chain of
arginine in F268R probably accommodated this by avoiding the
unfavorable interactions with the nearby basic residues, such as K255
or R274, and interacting with Glu115 (Fig. 9) on the neighboring
subunit and allowed the monomer-monomer interaction. However, only
some, but not all, trimers which could remain attached to VP3 subcores
after purification were detectable in CLP preparations. In contrast,
W119D was not able to form stable multimers of trimers, indicating that
the mutations in this site, although targeted to monomer-monomer
contacts, had a profound effect on the stability of CLPs, possibly due
to an indirect effect on multimerization of trimers. By changing the
tryptophan to aspartate at the interface, the local nonpolar environment (Fig. 9), which is surrounded by methionine (M253) and
alanine (A341), would have been disrupted. This could result in the
interference on correct oligomerization of VP7, highlighting the role
of the VP7 trimer in core assembly. In addition, aspartate could also
interact with the nearby lysine 255 via a side chain, causing some
alteration in oligomerization. For the last VP7 mutant, a charged
hydrophilic arginine residue was substituted for the threonine at
position 321, near the C terminus of the molecule. The substitution at
this position also affected the CLP stability. This was probably
caused by electrostatic repulsion of the two arginine residues (aa 111 and aa 274) (Fig. 9) in close proximity and probably also influenced
the trimer-trimer interaction.
The effects of these VP7 mutations on CLP formation clearly indicate
that VP7 trimer formation could not accommodate most of the designed
point mutations without any functional effect on capsid assembly. The
crystallization data have demonstrated that the VP7 molecule, although
rigid in part, is yet capable of significant structural rearrangement
(3). From our biochemical and biological studies, it appears
that the interactions between subunits are highly specific and mostly
inflexible, which is not apparent from the VP7 atomic structural
analysis. Our studies have clearly identified a series of key residues
that are responsible for correct VP7 trimer formation and have
revealed their influence on VP7-VP3 interactions during core assembly.
The structural analysis revealed that the interactions between the
various VP7 trimers are relatively nonspecific, involving a set of
hydrophobic residues forming a thin band around the lower domains.
There is only a limited contact area in the interfaces, indicating that
the trimer-trimer interactions are relatively weak. The instability of
the CLPs in these experiments were likely due to the unstable
interactions between the various mutant trimers, indicating that subtle
alterations (such as bonding angle or subunit conformation) within a
trimer could have a profound effect on trimer-trimer interaction,
although formation of stable trimers was still achieved. Thus, the
formation of VP7 lattice on the core surface requires the exact fitting of 260 VP7 trimers. In addition, the mutations might also have influenced indirectly the interactions between the VP7 trimers and the
VP3 subcore by slightly changing the flat surface of the bottom of the
trimer. The results obtained in this report have supplemented the
atomic structure of VP7 and have generated biochemical and biological
information revealing the significance of correct oligomerization of
VP7 in core assembly.
 |
ACKNOWLEDGMENTS |
We thank D. Stuart and J. Grimes (University of Oxford) for
designing the mutations. We are very grateful to Ian M. Jones (IVEM),
Peter E. Prevelige, Jr. (UAB), and Vijay Reddy (The Scripps Research
Institute, La Jolla, Calif.) for very fruitful discussions during the
preparation of the manuscript.
This work was partly funded by grants from the NIH (United States) and
the BBSRC (United Kingdom).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: NERC Institute
of Virology and Environmental Microbiology, Mansfield Road, Oxford OX1 3SR, United Kingdom. Phone: 44 1865 281640. Fax: 44 1865 281696. E-mail: por{at}wpo.nerc.ac.uk.
 |
REFERENCES |
| 1.
|
Bairoch, A., and B. Boeckmann.
1990.
The SWISSPROT protein sequence bank.
Nucleic Acids Res.
19:2247-2248.
|
| 2.
|
Basak, A. K.,
P. Gouet,
J. Grimes,
P. Roy, and D. I. Stuart.
1996.
Crystal structure of the top domain of African horsesickness virus VP7: comparisons with bluetongue virus VP7.
J. Virol.
70:3797-3806[Abstract].
|
| 3.
|
Basak, A. K.,
J. Grimes,
P. Gouet,
P. Roy, and D. I. Stuart.
1997.
Structures of orbivirus VP7: implications for the role of this protein in the viral life cycle.
Structure
5:871-883[Medline].
|
| 4.
|
Basak, A. K.,
D. I. Stuart, and P. Roy.
1992.
Preliminary crystallographic study of bluetongue virus capsid protein, VP7.
J. Mol. Biol.
228:687-689[CrossRef][Medline].
|
| 5.
|
Belyaev, A. S., and P. Roy.
1992.
Presentation of hepatitis B virus preS2 epitope on bluetongue virus core-like particles.
Virology
190:840-844[CrossRef][Medline].
|
| 6.
|
Brown, M., and P. Faulkner.
1977.
A plaque assay for nuclear polyhedrosis viruses using a solid overlay.
J. Gen. Virol.
36:361-364[CrossRef].
|
| 7.
|
Eaton, B. T.,
A. R. Gould,
A. D. Hyatt,
B. E. Coupar,
J. C. Martyn, and J. R. White.
1991.
A bluetongue serogroup-reactive epitope in the amino terminal half of the major core protein VP7 is accessible on the surface of bluetongue virus particles.
Virology
180:687-696[CrossRef][Medline].
|
| 8.
|
Felgner, P. L.,
T. R. Gadek,
M. Holm,
R. Roman,
H. W. Chan,
H. Wenz,
J. P. Northrop,
G. M. Ringold, and M. Danielsen.
1987.
Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure.
Proc. Natl. Acad. Sci. USA
84:7413-7417[Abstract/Free Full Text].
|
| 9.
|
French, T. J., and P. Roy.
1990.
Synthesis of bluetongue virus (BTV) core-like particles by a recombinant baculovirus expressing the two major structural core proteins of BTV.
J. Virol.
64:1530-1536[Abstract/Free Full Text].
|
| 10.
|
Gouet, P.,
J. M. Diprose,
J. M. Grimes,
R. Malby,
J. N. Burroughs,
S. Zientara,
D. I. Stuart, and P. P. C. Mertens.
1999.
The highly ordered double-stranded RNA genome of bluetongue virus revealed by crystallography.
Cell
97:481-490[CrossRef][Medline].
|
| 11.
|
Grimes, J.,
A. K. Basak,
P. Roy, and D. I. Stuart.
1995.
The crystal structure of bluetongue virus VP7.
Nature
373:167-170[CrossRef][Medline].
|
| 12.
|
Grimes, J. M.,
J. Jakana,
M. Ghosh,
A. K. Basak,
P. Roy,
W. Chiu,
D. I. Stuart, and B. V. V. Prasad.
1997.
An atomic model of the outer layer of the bluetongue virus core derived from X-ray crystallography and electron cryomicroscopy.
Structure
5:885-893[Medline].
|
| 13.
|
Grimes, J. M.,
J. N. Burroughs,
P. Gouet,
J. M. Diprose,
R. Malby,
S. Zientara,
P. P. C. Mertens, and D. I. Stuart.
1998.
The atomic structure of the bluetongue virus core.
Nature
395:470-478[CrossRef][Medline].
|
| 14.
|
Hewat, E. A.,
T. F. Booth,
P. T. Loudon, and P. Roy.
1992.
3-D reconstruction of bluetongue virus core-like particles by cryo-electron microscopy.
Virology
189:10-20[CrossRef][Medline].
|
| 15.
|
Iwata, H.,
T. Chuma, and P. Roy.
1992.
Characterization of the genes encoding two of the major capsid proteins of epizootic haemorrhagic disease virus indicates a close genetic relationship to bluetongue virus.
J. Gen. Virol.
73:915-924[Abstract/Free Full Text].
|
| 16.
|
King, L. A., and R. D. Possee.
1992.
The baculovirus expression system. A laboratory guide.
Chapman & Hall, London, United Kingdom.
|
| 17.
|
Kitts, P. A., and R. D. Possee.
1993.
A method for producing recombinant baculovirus expression vectors at high efficiency.
BioTechniques
14:810-817[Medline].
|
| 18.
|
Kowalik, T. F., and J. K. Li.
1989.
Sequence analyses and structural predictions of double-stranded RNA segment S1 and VP7 from United States prototype bluetongue virus serotypes 13 and 10.
Virology
172:189-195[CrossRef][Medline].
|
| 19.
|
Kowalik, T. F., and J. K. Li.
1991.
Bluetongue virus evolution: sequence analyses of the genomic S1 segments and major core protein VP7.
Virology
181:749-755[CrossRef][Medline].
|
| 20.
|
Kowalik, T. F.,
J. K. Li,
R. Y. Chuang,
R. H. Doi, and B. I. Osburn.
1990.
The complete nucleotide and deduced amino acid sequence of the gene encoding the major inner capsid protein, VP7 of US bluetongue virus serotype 17.
Nucleic Acids Res.
18:5302[Free Full Text].
|
| 21.
|
Kraulis, P. J.
1991.
MOLSCRIPT: a program to produce both detailed and schematic plots of protein.
J. Appl. Crystallogr.
24:946-950[CrossRef].
|
| 22.
|
Kunkel, T. A.,
J. D. Roberts, and R. A. Zakuor.
1987.
Rapid and efficient method of site-specific mutagenesis without phenotypic selection.
Methods Enzymol.
154:367-382[Medline].
|
| 23.
|
LeBlois, H., and P. Roy.
1993.
A single point mutation in the VP7 major core protein of bluetongue virus prevents the formation of core-like particles.
J. Virol.
67:353-359[Abstract/Free Full Text].
|
| 24.
|
Livingstone, C., and I. M. Jones.
1989.
Baculovirus expression vector with single-strand capability.
Nucleic Acids Res.
17:2366[Free Full Text].
|
| 25.
|
Monastyrskaya, K.,
N. Staeuber, and P. Roy.
1997.
Effects of domain-switching and site-directed mutagenesis on the properties and functions of the VP7 proteins of two orbiviruses.
Virology
237:217-227[CrossRef][Medline].
|
| 26.
|
Moss, S. R.,
L. D. Jones, and P. A. Nuttall.
1992.
Comparison of the major structural core proteins of tick-borne and Culicoides-borne orbiviruses.
J. Gen. Virol.
73:2585-2590[Abstract/Free Full Text].
|
| 27.
|
Oldfield, S.,
A. Adachi,
T. Urakawa,
T. Hirasawa, and P. Roy.
1990.
Purification and characterization of the major group-specific core antigen VP7 of bluetongue virus synthesized by a recombinant baculovirus.
J. Gen. Virol.
71:2649-2656[Abstract/Free Full Text].
|
| 28.
|
Plaxco, K. W.,
C. Spitzfaden,
I. D. Campbell, and C. M. Dobson.
1996.
Rapid refolding of a proline-rich all- -sheet fibronectin type III module.
Proc. Natl. Acad. Sci. USA
93:10703-10706[Abstract/Free Full Text].
|
| 29.
|
Prasad, B. V. V.,
S. Yamaguchi, and P. Roy.
1992.
Three-dimensional structure of single-shelled BTV.
J. Virol.
66:2135-2142[Abstract/Free Full Text].
|
| 30.
|
Roy, P.
1992.
Bluetongue virus proteins.
J. Gen. Virol.
73:3051-3064[Abstract/Free Full Text].
|
| 31.
|
Roy, P.
1995.
Orbiviruses and their replication, p. 1709-1734.
In
B. N. Fields (ed.), Fields' virology, 3rd ed., vol. 1. Lippincott-Raven Publishers, Philadelphia, Pa.
|
| 32.
|
Roy, P.
1996.
Orbivirus structure and assembly.
Virology
216:1-11[CrossRef][Medline].
|
| 33.
|
Roy, P., and P. P. C. Mertens.
1999.
Orbiviruses and coltiviruses: molecular biology, p. 1062-1074.
In
A. Granoff, and R. G. Webster (ed.), Encyclopaedia of virology, 2nd ed. Academic Press, London, United Kingdom.
|
| 34.
|
Roy, P.,
T. Hirasawa,
M. Fernandez,
V. M. Blinov, and J. M. Sanchez-Vizcaino Rodriquez.
1991.
The complete sequence of the group-specific antigen, VP7, of African horsesickness virus serotype 4 reveals a close relationship to bluetongue virus.
J. Gen. Virol.
72:1237-1241[Abstract/Free Full Text].
|
| 35.
|
Roy, P.,
J. J. A. Marshall, and T. J. French.
1990.
Structure of bluetongue virus genome and its encoded proteins.
Curr. Top. Microbiol. Immunol.
162:43-87[Medline].
|
| 36.
|
Sanger, J. A.,
S. Nicklen, and A. R. Coulson.
1977.
DNA sequencing with chain-terminating inhibitors.
Proc. Natl. Acad. Sci. USA
74:5463-5467[Abstract/Free Full Text].
|
| 37.
|
Wade-Evans, A. M.
1990.
The complete nucleotide sequence of genome segment 7 of bluetongue virus, serotype 1 from South Africa.
Nucleic Acids Res.
18:4919[Free Full Text].
|
Journal of Virology, September 2000, p. 8658-8669, Vol. 74, No. 18
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Bhattacharya, B., Roy, P.
(2008). Bluetongue Virus Outer Capsid Protein VP5 Interacts with Membrane Lipid Rafts via a SNARE Domain. J. Virol.
82: 10600-10612
[Abstract]
[Full Text]
-
Mateo, R., Luna, E., Mateu, M. G.
(2007). Thermostable variants are not generally represented in foot-and-mouth disease virus quasispecies. J. Gen. Virol.
88: 859-864
[Abstract]
[Full Text]
-
Kar, A. K., Iwatani, N., Roy, P.
(2005). Assembly and Intracellular Localization of the Bluetongue Virus Core Protein VP3. J. Virol.
79: 11487-11495
[Abstract]
[Full Text]
-
Reguera, J., Carreira, A., Riolobos, L., Almendral, J. M., Mateu, M. G.
(2004). Role of interfacial amino acid residues in assembly, stability, and conformation of a spherical virus capsid. Proc. Natl. Acad. Sci. USA
101: 2724-2729
[Abstract]
[Full Text]
-
Kar, A. K., Roy, P.
(2003). Defining the Structure-Function Relationships of Bluetongue Virus Helicase Protein VP6. J. Virol.
77: 11347-11356
[Abstract]
[Full Text]
-
Mateo, R., Diaz, A., Baranowski, E., Mateu, M. G.
(2003). Complete Alanine Scanning of Intersubunit Interfaces in a Foot-and-Mouth Disease Virus Capsid Reveals Critical Contributions of Many Side Chains to Particle Stability and Viral Function. J. Biol. Chem.
278: 41019-41027
[Abstract]
[Full Text]
-
Limn, C.-K., Roy, P.
(2003). Intermolecular Interactions in a Two-Layered Viral Capsid That Requires a Complex Symmetry Mismatch. J. Virol.
77: 11114-11124
[Abstract]
[Full Text]
-
Kim, J., Zhang, X., Centonze, V. E., Bowman, V. D., Noble, S., Baker, T. S., Nibert, M. L.
(2002). The Hydrophilic Amino-Terminal Arm of Reovirus Core Shell Protein {lambda}1 Is Dispensable for Particle Assembly. J. Virol.
76: 12211-12222
[Abstract]
[Full Text]
-
Tan, B.-H., Nason, E., Staeuber, N., Jiang, W., Monastryrskaya, K., Roy, P.
(2001). RGD Tripeptide of Bluetongue Virus VP7 Protein Is Responsible for Core Attachment to Culicoides Cells. J. Virol.
75: 3937-3947
[Abstract]
[Full Text]